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Introduction Complex vesico-vaginal fistula (VVF) has a high  recurrence rate and so the repair with graft 
tissues seems to be favorable. Amniotic membrane (AM) plays an increasing role as a scaffold for the repair 
of defect tissue due to its unique biological properties with regard to promoting wound healing.
Material and methods An innovative surgical procedure for AM-assisted repair of a complex vesico-vaginal 
fistula as the Idea Stage following the IDEAL recommendations is presented. The development of amnion 
preparation and the involved surgical steps are described.
Results We are able to report a successful repair of VVF by abdominal approach with an amniotic mem-
brane graft. Good functional results, no adverse events and no graft rejection have  been detected.
Conclusions Favorable results confirm the technical simplicity, safety and efficacy of this procedure.  
Following the IDEAL recommendations, consecutive animal experiments and a cohort study are in prog-
ress.
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INTRODUCTION
Vesico-vaginal fistulae (VVF) are frequently caused 
by complex onco-gynecologic or pelvic surgery and 
may be aggravated by oncologically necessary ra-
diotherapy. These procedures are known to lead to 
symptoms such as permanent incontinence, leakage 
of urine from the vagina, infection and pain; there-
fore, significantly deteriorating the quality of living 
for the affected women [1]. In addition, numerous 
surgical procedures (in several cases requiring multi-
ple interventions) for fistula repair like urinary diver-
sion, etc. may worsen the situation for these patients 
[2]. New individual approaches with graft applica-
tions are therefore indicated to improve the local ana-
tomical conditions and to reduce the symptoms. Sev-
eral biological and artificial materials have been used, 
but can lead to further complications such as rejec-
tion, necrosis and infection. First reports of amnion 
application into the pelvic region have shown fast 
epithelialization and improved functionality in vagi-
nal and bladder reconstruction, but, so far, there is 
no standardized procedure [3, 4]. 
Patient-tailored innovative surgical approaches are 
difficult to standardize and respective recommenda-
tions cannot easily be generalized. A new approach, 
the IDEAL method has been proposed in 2009 
by Mc Culloch and colleagues [5]. The IDEAL proce-
dure clearly provides stages of surgical innovations, 
which allow for the ability to assign a new method 
to its specific level of development and evidence. 
For the first time, we present a VVF repair with am-
niotic membrane as the “Idea level” following the 
IDEAL recommendations.
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MATERIAL AND METHODS
A 64-year old female was admitted to our hospital with 
sigma diverticulitis and chronic vesico-vaginal fistula 
(VVF). She had a previous history of cervical cancer 
and radio-chemotherapy for anal cancer with com-
plete remission. The resection of the sigma-bowel and 
fistula were performed in our department of surgery. 
However, VVF persisted after multiple abdominal op-
erations. The patient suffered due to permanent incon-
tinence and local skin infection. After a recovery period 
of 3 months, we reevaluated the patient with cystog-
raphy, cystoscopy, ureteropyelography and vaginal 
examination. Complex vesico-vaginal fistula of 1.5 cm 
was detected at the apical anterior vaginal wall lead-
ing to the bladder base (Figure 1). Additionally, scar-
ring of the vagina and distal ureters was found and the 
patient suffered from a persistent MRSA-colonization 
of the urine. Due to the complex situation, we dis-
cussed an individualized treatment strategy with the 
off-label use of amniotic membrane (AM). Prior to the 
operation, AM was obtained immediately after elective 
cesarean sections with normal gestation. The donors 
were screened for infections including HIV, hepatitis 
and syphilis after informed consent. The placenta was 
cleaned with balanced salt solution and the amnion 
was separated from the chorion by blunt dissection 
under the laminar flow. The separated membranes 
were cut and after several rinsing steps the amnion 
was frozen at -20°C for 24 hours until further use. For 
further processing, the AM was defrosted in the water, 
sterilized in peracetic acid andalcohol mixture, then 
incubated for 2 hours on the shaker. After rinsing the 
amnion was applied on a sterile silicon scaffold and 
dried under laminar flow. Prior to surgery, three lay-
ers of dried AM were fixed together by a 4-0 Monocryl 
suture. During the surgery single-shot antibiotic was 
given and an extraperitoneal abdominal approach 
was chosen to allow maximum exposure. The perito-
neum was dissected off the bladder dome and poste-
rior bladder wall. The incision was carried out through 
the anterior bladder wall to prepare the fistula. The 
ureteric orifices were found outside the fistula region. 
The fistulous tract and all devitalized tissue were ex-
cised sparingly. The multilayer AM of 4 cm size was 
used as a graft to close the defect and was fixed with 
4-0 Monocryl sutures at the edges of the normal blad-
der wall. The anterior bladder wall was then closed 
and ureteric stents were led out in a suprapubic region 
to dry the bladder. Topical oestrogen was prescribed 
for 3 weeks after surgery. Anti-muscarinic therapy was 
started to restore the bladder capacity. 
RESULTS
Seven days after the surgery a cystography was per-
formed showing no leakage. In the three following 
months a reevaluation with cystography, cystoscopy 
and vaginal examination was performed with no signs 
of recurrent fistula and full recovery of the vaginal 
epithelium was presented (Figure 2). The ureter 
stents were internalized and the patient was able to 
micturate without incontinence. The bladder capac-
ity was restored to the volume of 250 ml. No severe 
complications and no signs of graft rejection were ob-
served during the follow-up of 6 months. The MRSA-
colonization in the urine was successfully eradicated.
DISCUSSION
Complex fistulae are characterized by a size >3–4 cm, 
involvement of the urethra, presence of ureteric ori-
fices, distinct vaginal scarring and multiple localiza-
tion. They usually present a poor outcome with high 
Figure 1. Preoperative examination. A. Cystography showing  
the vaginal contrast leakage, indwelling ureteral stents.  
B. Cystoscopy showing the fistula canal at the bottom of the 
bladder. 
Figure 2. Postoperative examination 3 months after the 
surgery. A. Cystography showing no contrast leakage, indwell-
ing ureteral stents and catheter. B. Cystoscopy showing the 
amnion graft. AM merged with the surrounding bladder tissue 
at the margins but was still clearly demarcated with no signs 
of overgrowing urothelium or stroma. *, fixation points with 
suture. 
recurrence rates and a devastating course [1, 2, 6, 7]. 
Literature on the post-radiation fistulae is still scarce. 
Radiation-induced recurrent vesico-vaginal fistulae 
have the lowest success rate in terms of successful 
treatment and require the most demanding interven-
tions [1]. The surgical approach to the repair of VVF 
depends on the surgeon’s experience, the type and lo-
cation of the fistula, and the patient’s specific prefer-
ences [1, 2, 6]. The trans-vaginal approach is preferred 
in the case of distal fistulae and has been associated 
with lower morbidity rates. However, the abdominal 
or even laparoscopic approaches are favorable for deep 
and large fistulae. For the repair of this specific condi-
tion an interposition flap is needed to substitute the 
defect. The type of vascularized interposition flap is 
determined by how proximal (peritoneal, O´Conor ap-
proach, muscle flap) or distal (Martius labial fat) the 
genitourinary fistula is located in the vagina (85–100% 
success) [1]. The used flaps have the risk of infection, 
necrosis, loss of function after time and long-term mor-
bidity. To avoid these problems different xeno-, homo- 
and autolog grafts have been proposed for the repair of 
VVF recently [1, 8]. Vascularization of the graft or flap 
is the main requirement for successful healing, other-
wise the recurrence of fistulae occurs frequently. 
The AM is the innermost layer of the placenta and 
is being increasingly applied in reconstructive surgery 
and tissue engineering (wound healing, ophthalmol-
ogy) due to its mechanical durability and "scaffolding" 
quality [9, 10]. The postoperative outcome after fistu-
la repair significantly depends on the degree of angio-
genesis and inflammation, which are regulated by the 
AM through cytokines (TGF-ß, IL-10) and growth fac-
tors (VEGF) [10]. The AM also has an immunomodu-
latory effect, with no relevant tissue rejection being 
described in previous allogen or xenogen experiments 
[10, 11]. AM might also be used as an economically 
reasonable and alternative biomaterial for the treat-
ment of VVF in developing countries with a high VVF 
incidence. 
Introducing new surgical methods, innovation, 
as well as medical devices does not yet follow clear 
paradigms as is the case for the approval process 
of new drugs. The IDEAL procedure suggests and 
clearly provides stages, which allow to assign every 
method to its particular level of development and evi-
dence. A new surgical method at the first “Idea level” 
should aim at proving a concept on a highly selected 
single-to-few patient basis. The suggested method 
of reporting should be a structured case report.
For the first time, we present a structured implemen-
tation of a new method for VVF repair following the 
IDEAL recommendations [5]. After positive results of 
this first case we plan consecutive prospective develop-
mental studies in an animal model and cohort studies.
CONCLUSIONS
We reported a successful repair of VVF by an abdomi-
nal approach with an AM graft. Favorable results 
confirmed the technical simplicity, safety and efficacy 
of this procedure in the first case. Further research 
with controlled and randomized trials will show 
if a general application of the amnion graft to repair 
defects like VVF can be recommended. 
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